|
|
Top 20 Japanese Companies & Their Pipelines 2009Published by: PharmaLive Special Reports Published: Oct. 1, 2009 - 77 Pages Table of Contents
AbstractIn spite of the global economic downturn, Japanese pharmaceutical companies are realizing growth by capitalizing on M&A opportunities, predominantly through acquisition of specialty and generic pharmaceutical companies based in the United States and Asia-Pacific region. In addition to expansion through acquisition strategies, Japanese pharmaceutical manufacturers may realize opportunities closer to home, as the Asia-Pacific region is a major emerging market for the development of orphan drugs. Many leading Asian countries have a legal framework for the development of novel medicines, and the market for the region is expected to notice significant growth. In fact, Japan's more than $60+ billion pharmaceutical market value is expected to top $100 billion by 2020. In this report, readers can access statistical data and analytical reviews of the top companies based in the country, identify the top therapeutic areas in terms of growth percentage for the region, gain insight into the M&A activity and future business strategy of Japanese companies growing their global presence, and track potential competitive products as Japanese companies look to expand into new markets.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||